Morbidity and Mortality Weekly Report: Recommendations and Reports, April 27, 2018 / Vol. 67 / No. RR-2

Details

• Alternative Title:
  Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States : Recommendations of the Advisory Committee on Immunization Practices (ACIP)
• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports
• Personal Author:
  Liang, Jennifer L. ; Tiwari, Tejpratap ; Moro, Pedro ; Messonnier, Nancy E. ; Reingold, Arthur ; Sawyer, Mark ; Clark, Thomas A.
• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.) ; United States. Advisory Committee on Immunization Practices. ; National Center for Immunization and Respiratory Diseases (U.S.). Division of Bacterial Diseases. ; National Center for Emerging and Zoonotic Infectious Disease (U.S.). Division of Healthcare Quality Promotion. ; National Center for Immunization and Respiratory Disease (U.S.) ; National Center for Chronic Disease Prevention and Health Promotion (U.S.). Division of Reproductive Health.
• Description:
  This report compiles and summarizes all recommendations from CDC’s Advisory Committee on Immunization Practices (ACIP) regarding prevention and control of tetanus, diphtheria, and pertussis in the United States. As a comprehensive summary of previously published recommendations, this report does not contain any new recommendations and replaces all previously published reports and policy notes; it is intended for use by clinicians and public health providers as a resource. ACIP recommends routine vaccination for tetanus, diphtheria, and pertussis. Infants and young children are recommended to receive a 5-dose series of diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccines, with one adolescent booster dose of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. Adults who have never received Tdap also are recommended to receive a booster dose of Tdap. Women are recommended to receive a dose of Tdap during each pregnancy, which should be administered from 27 through 36 weeks’ gestation, regardless of previous receipt of Tdap. After receipt of Tdap, adolescents and adults are recommended to receive a booster tetanus and diphtheria toxoids (Td) vaccine every 10 years to assure ongoing protection against tetanus and diphtheria.
  
  Suggested citation for this article: Liang JL, Tiwari T, Moro P, et al. Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2018;67(No. RR-2):1–44. DOI: http://dx.doi.org/10.15585/mmwr.rr6702a1.
  
  
• Subjects:
  Diphtheria Diphtheria-Tetanus-acellular Pertussis Vaccines Immunization Schedule Pregnancy Tetanus Vaccination Whooping Cough
• Source:
  Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports, 2018; v. 67, no. 2
• Series:
  Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  1057-5987 (print) ; 1545-8601 (digital)
• Pubmed ID:
  29702631
• Pubmed Central ID:
  PMC5919600
• Document Type:
  Journal Issue
• Place as Subject:
  United States
• Location:
  North America
• Pages in Document:
  48 pdf pages
• Volume:
  67
• Issue:
  2
• Collection(s):
  Guidelines and Recommendations Advisory Committee on Immunization Practices (ACIP) Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:7df8dda04502213e5eac60a198f2ea0691787695776a7ded4e74df36e21cce751ea1ae36d1b982b57da8dfe51c329afd50588fe4b9dfb6cf6c13dc790c7d9f7a
• Download URL:
  https://stacks.cdc.gov/view/cdc/53561/cdc_53561_DS1.pdf
• File Type:
  [PDF - 670.74 KB ]